Anti-HIV efficacy and biodistribution of nucleoside reverse transcriptase inhibitors delivered as squalenoylated prodrug nanoassemblies

详细信息    查看全文

• 作者：Hervé ; Hillaireau^a ; ^b ; ¹ ; Nathalie Dereuddre-Bosquet^c ; ^d ; ¹ ; Rym Skanji^a ; ^b ; Fawzia Bekkara-Aounallah^a ; ^b ; ^e ; Joachim Caron^a ; ^b ; Sinda Lepê ; tre^a ; ^b ; Sé ; bastien Argote^f ; Laurent Bauduin^g ; Rahima Yousfi^c ; Christine Rogez-Kreuz^c ; Didier Desma&euml ; le^a ; ^b ; Bernard Rousseau^f ; Ruxandra Gref^a ; ^b ; Karine Andrieux^a ; ^b ; Pascal Clayette^c ; Patrick Couvreur^a ; ^b ; ^{patrick.couvreur@u-psud.fr}
• 关键词：Squalenoylation ; Nanoassemblies ; Prodrug ; Didanosine ; Zalcitabine
• 刊名：Biomaterials
• 出版年：2013
• 出版时间：July, 2013
• 年：2013
• 卷：34
• 期：20
• 页码：4831-4838
• 全文大小：1001 K

文摘

Due to their hydrophilic nature, most nucleoside reverse transcriptase inhibitors (NRTIs) display a variable bioavailability after oral administration and a poor control over their biodistribution, thus hampering their access to HIV sanctuaries. The limited cellular uptake and activation in the triphosphate form of NRTIs further restrict their efficacy and favour the emergence of viral resistance. We have shown that the conjugation of squalene (sq) to the nucleoside analogues dideoxycytidine (ddC) and didanosine (ddI) leads to amphiphilic prodrugs (ddC-sq and ddI-sq) that spontaneously self-organize in water as stable nanoassemblies of 100-300?nm. These nanoassemblies can also be formulated with polyethylene glycol coupled to either cholesterol (Chol-PEG) or squalene (sq-PEG). When incubated with peripheral blood mononuclear cells (PBMCs) in?vitro infected with HIV, the NRTI-sq prodrugs enhanced the antiviral efficacy of the parent NRTIs, with a 2- to 3-fold decrease of the 50 % effective doses and a nearly 2-fold increase of the selectivity index. This was also the case with HIV-1 strains resistant to ddC and/or ddI. The enhanced antiviral activity of ddI-sq was correlated with an up to 5-fold increase in the intracellular concentration of the corresponding pharmacologically active metabolite ddA-TP. The ddI-sq prodrug was further investigated in?vivo by the oral route, the preferred route of administration of NRTIs. Pharmacokinetics studies performed on rats showed that the prodrug maintained low amounts of free ddI in the plasma. Administration of ³H-ddI-sq led to radioactivity levels higher in the plasma and relevant organs in HIV infection as compared to administration of free ³H-ddI. Taken together, these results show the potential of the squalenoylated prodrugs of NRTIs to enhance their absorption and improve their biodistribution, but also to enhance their intracellular delivery and antiviral efficacy towards HIV-infected cells.